IsoRay, Inc.(NYSE Amex Equities : ISR)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
Health Technology » Pharmaceuticals Other
|SAVA||Cassava Sciences, Inc.||-1.83%||45.71||0.0%||$248.51m|
|VRX||Valeant Pharmaceuticals International, Inc.||0.49%||28.73||14.1%||$169.05m|
|HZNP||Horizon Therapeutics Plc||-0.01%||116.45||5.5%||$129.22m|
|JAZZ||Jazz Pharmaceuticals Plc||0.49%||144.84||2.1%||$90.49m|
|PRGO||Perrigo Co. Plc||-0.39%||45.61||6.9%||$73.61m|
|UTHR||United Therapeutics Corp.||0.18%||191.01||14.0%||$67.59m|
|AXSM||Axsome Therapeutics, Inc.||-1.76%||40.10||1.8%||$37.93m|
|BHC||Bausch Health Cos., Inc.||0.49%||28.73||0.0%||$34.17m|
|ENDP||Endo International Plc||0.44%||4.56||8.5%||$31.70m|
|RVNC||Revance Therapeutics, Inc.||-2.03%||15.44||6.1%||$31.59m|
|PCRX||Pacira Biosciences, Inc.||-0.96%||52.61||9.8%||$30.82m|
IsoRay, Inc. is a medical technology company, which engages in the development, manufacture, and sale of isotope-based medical products and devices. The firm focuses on the treatment of cancer and other malignant diseases. Its core product is Cesium-131, a radioisotope for the treatment of malignant tumors. The company was founded by Lance A. Bray in 1983 and is headquartered in Richland, WA.